Tessari Eben sold KNSA
November 26, 2025 · Form 4 insider transaction
Tessari Eben sold 200 shares of Kiniksa Pharmaceuticals International, plc at $42.89 per share, a transaction worth $8.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$42.89
Total value
$8.6K
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateNovember 26, 2025
Filing dateDecember 1, 2025
Shares owned after22,714
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.